List your practice on InjuredCare | Log in / Sign up

Adderall and Ritalin

Adderall and Ritalin

Drugs Commonly Used to Treat Attention Deficit Hyperactivity Disorder (ADHD)

Adderall and Ritalin are prescription drugs used to treat individuals with attention deficit hyperactivity disorder (ADHD) and narcolepsy, a condition involving difficulty managing sleep-wake cycles. ADHD is most commonly found in young children and adolescents and is characterized by difficulty paying attention, excessive activity, busyness, or behavior that is age inappropriate. Adderall is what is known as a "combination medication," containing four different types of amphetamines. Ritalin is the trade name for the chemical compound methylphenidate. Both Adderall and Ritalin are stimulants.

Adderall is actually a rebrand or renaming of an earlier drug known as Obetrol. Obetrol was marketed in the 1960s as a weight-control drug but was pulled from the market in 1973 by its manufacturer, Rexar. Rexar reformulated the product and brought it back on the market. In 1994, Richwood Pharmaceuticals acquired Rexar, renamed Obetrol as Adderall (a contraction of "A.D.D. for All") and began marketing it for the treatment of attention deficit disorder. After discussions with the FDA, Adderall was approved for sale and marketing in the United States in 1996.

Methylphenidate was first synthesized in 1944 and was used in the 1960s to treat children diagnosed with ADHD. The FDA approved Ritalin for sale and marketing in the United States in 1961. An extended release form was approved by the FDA in 2000, sold under the brand name Concerta.

Adderall has been tied to a wide range of adverse side effects, often based on dosage. Physical side effects include cardiovascular problems, often related to high or low blood pressure. Adderall also has been linked to Raynaud's phenomenon, where patients experience reduced blood flow to extremities. A number of gastrointestinal conditions are associated with the drug, including nausea, diarrhea, constipation, and abdominal pain. Users have reported loss of appetite, dry mouth, blurred vision, weight loss, seizures, and excessive grinding of the teeth. Sexual dysfunction also may be a consequence.

Though Ritalin has generally been well-tolerated, patients have reported interruptions in sleep patterns, heart problems, anxiety, and weight loss.

Related Articles

  • Failure to Diagnose and Misdiagnosis of Medical Conditions

    Failure to Diagnose and Misdiagnosis of Medical Conditions

    The Common Types of Medical Diagnostic Mistakes When you're experiencing health problems, one of the first things you want and need is an accurate diagnosis of the problem. Unfort Read More...

  • Actos

    Actos

    Actos (pioglitazone) is manufactured by Takeda Pharmaceuticals and was approved by the FDA July 15, 1999, for the treatment of Type-2 diabetes. Marketed by Eli Lilly in the U.S., A Read More...

  • Pradaxa

    Pradaxa

    The Trade or Brand Name for the Anticoagulant Dabigatran First approved by the U.S. Food and Drug Administration (FDA) in October 2010, dabigatran is used primarily to treat and p Read More...

© 2015-2022 LawConnect, Inc. All rights reserved.

CONCEPT, DESIGN and HOSTING BY GETLEGAL.COM’S WEB SERVICES TEAM..